Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$832M |
| 2 |
Johnson & Johnson
JNJ
|
+$706M |
| 3 |
Datadog
DDOG
|
+$549M |
| 4 |
Amazon
AMZN
|
+$442M |
| 5 |
Eli Lilly
LLY
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$1.22B |
| 2 |
AbbVie
ABBV
|
+$1.07B |
| 3 |
Advanced Micro Devices
AMD
|
+$817M |
| 4 |
Amgen
AMGN
|
+$706M |
| 5 |
Honeywell
HON
|
+$659M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.69% |
| 2 | Healthcare | 17.58% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Financials | 10.23% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LINE
201
Lineage Inc
LINE
$9.69B
| $189M | 0.1% |
3,233,219
+1,550,478
| +92% | +$105M |
|
202
Humana
HUM
$45.8B
| $184M | 0.09% |
724,404
-179,044
| -20% | -$48M |
|
203
Freeport-McMoran
FCX
$90.2B
| $182M | 0.09% |
4,776,449
-395,770
| -8% | -$17.7M |
|
204
AXIS Capital
AXS
$8.63B
| $181M | 0.09% |
2,042,925
+20,976
| +1% | +$1.8M |
|
205
Walker & Dunlop
WD
$1.69B
| $179M | 0.09% |
1,845,100
+8,571
| +0.5% | +$928K |
|
206
Alibaba
BABA
$276B
| $179M | 0.09% |
2,112,187
+1,030,999
| +95% | +$97.4M |
|
207
Dyne Therapeutics
DYN
$4.24B
| $174M | 0.09% |
7,379,309
+566,146
| +8% | +$16.7M |
|
208
Zai Lab
ZLAB
$2.1B
| $172M | 0.09% |
6,567,892
-2,192,182
| -25% | -$60.8M |
|
209
S&P Global
SPGI
$130B
| $172M | 0.09% |
344,856
+55,376
| +19% | +$28.1M |
|
210
Crown Holdings
CCK
$12.9B
| $169M | 0.09% |
2,044,383
-778,711
| -28% | -$70.9M |
|
|
AKRO
211
DELISTED
Akero Therapeutics
AKRO
| $168M | 0.09% |
6,034,239
-1,043,239
| -15% | -$31.6M |
|
212
Trip.com Group
TCOM
$28.2B
| $166M | 0.08% |
2,412,761
+471,768
| +24% | +$31.2M |
|
213
United Therapeutics
UTHR
$26.3B
| $165M | 0.08% |
468,996
+8,577
| +2% | +$3.15M |
|
214
Glaukos
GKOS
$8.92B
| $164M | 0.08% |
1,092,417
-233,367
| -18% | -$32.1M |
|
215
Sensient Technologies
SXT
$5.32B
| $161M | 0.08% |
2,257,033
+25,230
| +1% | +$1.94M |
|
216
IBM
IBM
$204B
| $160M | 0.08% |
729,479
-141,585
| -16% | -$31.5M |
|
217
Cisco
CSCO
$452B
| $159M | 0.08% |
2,687,382
-16,567
| -0.6% | -$946K |
|
|
SUM
218
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $157M | 0.08% |
3,096,383
+324,902
| +12% | +$15.2M |
|
219
Philip Morris
PM
$305B
| $156M | 0.08% |
1,297,023
+831,580
| +179% | +$105M |
|
220
Ryan Specialty Holdings
RYAN
$5.59B
| $156M | 0.08% |
2,431,193
-717,723
| -23% | -$50M |
|
221
Stride
LRN
$3.83B
| $155M | 0.08% |
1,493,709
+323,275
| +28% | +$30.8M |
|
222
Shift4
FOUR
$3.96B
| $151M | 0.08% |
1,456,002
+2,202
| +0.2% | +$219K |
|
223
IDEAYA Biosciences
IDYA
$3.54B
| $151M | 0.08% |
5,857,639
+695,263
| +13% | +$19.7M |
|
224
Ares Management
ARES
$28.8B
| $150M | 0.08% |
845,307
-23,707
| -3% | -$4.04M |
|
225
Magnolia Oil & Gas
MGY
$5.53B
| $150M | 0.08% |
6,396,875
+667,973
| +12% | +$17.4M |
|
Similar funds
Janus Henderson Group's Q4 2024 Portfolio in Review
As of Q4 2024, Janus Henderson Group held 2,620 positions worth $197B, up 0.7% from $195B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Janus Henderson Group's Q4 2024 filing shows 92 new, 801 increased, 713 reduced and 96 closed positions. Its largest new stake was Lam Research: 10,967,975 shares worth $792M. The largest sale was Workday, an estimated $1.22B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2024 buy was Lam Research: 10,967,975 shares worth $792M.
- Janus Henderson Group added most to Johnson & Johnson in Q4 2024, an estimated $706M increase.
- Janus Henderson Group's biggest Q4 2024 reduction was Workday, cutting an estimated $1.22B.
- Janus Henderson Group fully exited Coca-Cola Europacific Partners in Q4 2024, selling an estimated $52.4M.
- Janus Henderson Group's ten largest holdings make up 32% of its $197B portfolio in Q4 2024.
- Janus Henderson Group opened 92 new positions and closed 96 in Q4 2024.
- Janus Henderson Group's portfolio value rose 0.7% quarter-over-quarter to $197B.
Based on Janus Henderson Group's 13F filing for Q4 2024, filed 14 Feb 2025.